AI assistant
Novonesis AS Major Shareholding Notification 2016
3377_rns_2016-11-30_6caf84e2-a05c-482b-8240-31259f7c0073.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Major shareholder announcement
November 30, 2016
Company announcement No. 58
In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 4.92% of the B shares in Novozymes, previously reported at 5.10% in company announcement no. 51, October 2016.
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,243,078 shares of a nominal value of DKK 30,486,156, equivalent to 4.92% of Novozymes A/S' share capital and 1.92% of the voting rights.
Contact information
[email protected]
Martin Riise
+45 3077 0738
[email protected]
Klaus Sindahl
+45 5363 0134
[email protected]
Nicolai Kobborg
+45 3077 1348
[email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27
Rethink Tomorrow
novozymes